MD&A · 2025
In this section4 topics
Overview of Operations
Overview of Operations
Techno Medical Public Company Limited operates as a distributor of medical devices and equipment. It imports medical devices and equipment from leading global manufacturers for distribution to healthcare facilities in Thailand, including government hospitals, private hospitals, clinics, and medical personnel. The products distributed by the company are modern medical devices and equipment that meet international standards, which are divided into two groups based on product usage characteristics. In 2023, a subsidiary (TM Nursing Care Co., Ltd., later renamed The Parents Co., Ltd.) launched a health innovation center for extended quality of life and elderly care, resulting in revenue from care-related services. Therefore, revenue groups are classified into three categories as follows:
1.Disposable and Supplies Group
2. Medical Equipment and Instrument Group
3. Nursing Care Services
Considering the overall performance of the company from 2023 to 2025, the company's sales revenue increased, with an average Compound Annual Growth Rate (CAGR) of 0.66 percent over this period. However, sales in 2023 increased due to increased sales of disposable surgical products and blood bank products, with market expansion into new hospitals since Q2/2022. Additionally, the subsidiary (The Parents Co., Ltd., formerly TM Nursing Care Co., Ltd.) commenced operations of an elderly care facility in 2023, leading to an increase in revenue from care-related services by 10.25 million baht.
Concurrently, sales in 2024 significantly increased due to increased sales of disposable surgical products and blood bank products, with market expansion into new hospitals since Q2/2022. Additionally, the subsidiary (The Parents Co., Ltd.) commenced operations of an elderly care facility in 2023, leading to an increase in revenue from care-related services to 15.46 million baht in 2024.
and sales in 2025 decreased due to a reduction in sales of surgical equipment and consumables caused by price competition, and the blood bank product group did not win the bid at the Red Cross. However, at the same time, revenue from care-related services increased to 22.57 million baht in 2025.
The company's total revenue in 2023, 2024, and 2025 was 702.67 million baht 730.16 million baht and 707.58 million baht, respectively. This is divided into sales revenue of 696.02 million baht, 725.18 million baht, and 705.16 million baht, or 99.05 percent, 99.28 percent, and 99.62 percent of total revenue, respectively. Other income amounted to 0.99 million baht, 0.83 million baht, and 1.22 million baht, or 0.14 percent, 0.11 percent, and 0.17 percent of total revenue, respectively.


Operating Results & Financial Condition
Operating Results & Profitability
Sales revenue by product type
Product group | 2023 | 2024 | 2025 | |||
Million Baht | % | Million Baht | % | Million Baht | % | |
| 657.20 | 94.43 | 699.30 | 96.43 | 674.65 | 95.67 |
| 28.56 | 4.10 | 10.42 | 1.44 | 7.94 | 1.13 |
| 10.25 | 1.47 | 15.46 | 2.13 | 22.57 | 3.20 |
Total sales revenue | 696.01 | 100.00 | 725.18 | 100.00 | 705.16 | 100.00 |
The company's sales revenue can be categorized into three product groups: Disposable and Supplies Group, Medical Equipment and Instrument Group and Nursing Care Services.
1. Revenue from sales of equipment and consumables
In 2023, 2024, and 2025, revenue from the sale of equipment and consumables in total 657.20 million baht, 699.30 million baht, and 674.65 million baht, respectively, representing 94.43%, 96.43%, and 95.67% of total sales revenue, respectively.
In 2024, sales significantly increased for disposable surgical products and blood bank products, as hospitals were able to resume normal surgical services, and continuous market expansion led to sustained sales growth. Compared to 2023, sales increased due to higher sales of disposable surgical products and blood bank products, with market expansion into new hospitals starting from Q2/2022, and continuous marketing for new products, such as Alcohol ball products, contributing to increased sales.
And in 2025, sales decreased due to intense price competition in the market for disposable surgical products, such as gloves and fluid management devices. Therefore, the company considered adjusting selling prices to compete. Sales of blood bank products also decreased due to unsuccessful bids. Nevertheless, the company continuously strives to reduce product costs.
2. Revenue from sales of medical devices and instruments
In 2023, 2024, and 2025, revenue from the medical devices and instruments group in total 28.56 million baht, 10.42 million baht, and 7.94 million baht, respectively, representing 4.10%, 1.44%, and 1.13% of total sales revenue, respectively. The decrease in revenue was due to the termination of a distributorship agreement with one company. However, the company has been evaluating new manufacturers and is continuously accelerating marketing efforts to regain sales in the medical device product group.
3. Revenue from care-related services
In 2023, the subsidiary (The Parents Co., Ltd.) launched The Parents Wellness and Rehabilitation Center, an elderly care facility, with an average of 20 service recipients per month in 2023.
Meanwhile, in 2024, the average number of service recipients was 30 per month, leading to an increase in service revenue from 10.25 million baht in 2024 to 15.46 million baht in 2024.
And in 2025, the average number of service recipients was 40 per month, leading to an increase in service revenue from 22.57 million baht.
Other income
The company's other income for the years 2023 – 2025 amounted to 0.99 million baht, 0.83 million baht, and 1.22 million baht, respectively, or an other income to total revenue ratio of 0.14%, 0.11%, and 0.17%, respectively. The majority of the company's other income consists of gains from the sale of unused assets.
Other income in 2024 decreased by 0.16 million baht or -16.16% compared to 2023, as in 2023 the company had a gain from the disposal of fully depreciated vehicles of 0.70 million baht, and assistance from the Department of Labour due to the COVID-19 pandemic of 0.31 million baht, and interest income from bank fixed deposits.
Other income in 2024 decreased by 0.16 million baht or 16.16% compared to 2023, as the company's only income in 2024 was from interest on bank fixed deposits.
And in 2025, the company had a gain from the disposal of fully depreciated vehicles of 0.16 million baht, income from earthquake insurance claims of 0.26 million baht, and interest income from fixed deposits.
Cost of sales and cost of services
Cost of sales is considered the company's main expense, as the company operates as a trading business. The primary cost of sales is the cost of purchased goods. For the years 2023 – 2025, the company's cost of sales amounted to 465.50 million baht, 494.39 million baht, and 454.87 million baht, respectively, or 66.25%, 67.40%, and 64.26% of sales revenue, respectively.
In 2023, the company's cost of sales was 465.50 million baht, representing a cost-to-sales revenue ratio of 66.25%. This was an increase of 51.17 million baht compared to the same period in 2022, which is consistent with the increased sales volume. Additionally, the subsidiary recorded depreciation of patient room equipment as cost of sales and began depreciating the patient building in January 2023, leading to an increase in the cost of sales.
In 2024, the company's cost of sales was 494.39 million baht, representing a cost-to-sales revenue ratio of 67.40%. This was an increase of 26.81 million baht compared to the same period in 2023, which is consistent with the increased sales volume. Additionally, the subsidiary recorded depreciation of patient room equipment as cost of sales and began depreciating the patient building in January 2023, leading to an increase in the cost of sales.
In 2025, the company's cost of sales was 454.87 million baht, representing a cost-to-sales revenue ratio of 64.26%. This was a decrease of 37.44 million baht compared to the same period in 2024, which is consistent with the decreased sales volume. Simultaneously, the subsidiary recorded depreciation of patient room equipment as cost of sales and began depreciating the patient building in January 2023, and increased sales also led to a corresponding increase in the cost of sales.
Distribution Cost and administrative expenses
Distribution Cost
For the years 2023 – 2025, distribution cost amounted to 90.64 million baht, 100.07 million baht, and 87.61 million baht, respectively, or distribution cost to total revenue ratio of 12.90%, 13.70%, and 12.38%, respectively. distribution cost primarily consist of personnel-related costs, as these are the main operating expenses of the company, including salaries, bonuses, recreation/employee welfare, and commissions, which are expenses aimed at promoting sales to meet the company's set targets.
In 2023, the company's distribution cost amounted to 90.64 million baht, a decrease of 4.26 million baht or 4.49% compared to the same period in 2022. This was due to a decrease in promotional expenses of 1.34 million baht, as a result of cost control measures, and a decrease in donation expenses of 2.91 million baht.
For the year 2024, the company's distribution cost amounted to 100.07 million baht, an increase of 9.43 million baht or 10.40% compared to the same period in 2023. This was due to an increase in donation expenses of 2.81 million baht, an increase in sample products of 3.55 million baht, an increase in shipping costs of 1.25 million baht, and an increase in product packing labour costs of 0.82 million baht, which is consistent with the increased sales.
In 2025, the company's distribution cost amounted to 87.61 million baht, a decrease of 12.46 million baht or -12.45% compared to the same period in 2024. This was due to a decrease in donation expenses of 2.59 million baht, a decrease in sample products of 4.12 million baht, a decrease in marketing/promotional expenses of 0.93 million baht, a decrease in vehicle fuel costs due to lower fuel prices of 0.38 million baht, a decrease in employee bonuses of 2.98 million baht, and a decrease in commissions of 1.47 million baht, which is consistent with the decreased sales.
Administrative expenses
For the years 2023 – 2025, administrative expenses amounted to 134.60 million baht, 141.96 million baht, and 117.87 million baht, respectively, or an administrative expense to total revenue ratio of 19.16%, 20.05%, and 16.65%, respectively. Administrative expenses primarily consist of salaries, bonuses, depreciation, and consulting fees, among others.
For the year 2023, the company's administrative expenses amounted to 134.60 million baht, representing an administrative expense to total revenue ratio of 19.16%. This was an increase of 17.20 million baht or 14.65%, primarily due to the company increasing its warehouse rental, leading to an increase in depreciation of right-of-use assets for warehouses and an increase in depreciation of medical demonstration equipment by 2.74 million baht. Utility expenses for warehouses increased by 1.33 million baht, and international travel expenses increased by 1.52 million baht, as executives attended trade shows to select new products. TM Nursing Care Co., Ltd. had administrative expenses of 10.46 million baht, comprising salaries, welfare, and employee expenses of 7.39 million baht, promotional consumables of 3.90 million baht, audit fees of 0.17 million baht, and professional/consulting fees of 1.39 million baht.
In 2024, the company's administrative expenses amounted to 141.96 million baht, representing an administrative expense to total revenue ratio of 19.44%. This was an increase of 7.36 million baht or 5.47%, primarily due to the subsidiary recording an impairment loss on assets from business cessation totaling 14.94 million baht, equivalent to 2.05%. Simultaneously, the company implemented internal cost control measures. Nevertheless, the company increased its warehouse rental, leading to an increase in depreciation of right-of-use assets for warehouses and an overall depreciation increase of 2.50 million baht. Utility expenses for warehouses increased by 0.45 million baht. The Parents Co., Ltd. had administrative expenses of 22.96 million baht, comprising salaries, welfare, and employee expenses of 6.05 million baht, promotional consumables of 10.33 million baht, audit fees of 0.15 million baht, and professional/consulting fees of 1.17 million baht. And in 2024.
In 2025, the company's administrative expenses amounted to 117.87 million baht, representing an administrative expense to total revenue ratio of 16.65%. This was a decrease of 26.17 million baht or -18.17%, primarily due to the company implementing internal cost control measures, a decrease in depreciation of 4.12 million baht, a decrease in employee bonuses of 3.01 million baht, a decrease in stationery/printing costs of 0.47 million baht, a decrease in employee training and seminar costs of 0.53 million baht. The Parents Co., Ltd. had administrative expenses of 16.25 million baht, a decrease of 6.71 million baht compared to 2024, comprising salaries, welfare, and employee expenses of 5.40 million baht, promotional consumables of 8.82 million baht, audit fees of 0.10 million baht, and professional/consulting fees of 1.31 million baht.
Gain from exchange rate
For the years 2023 - 2025, the company reported exchange rate gains of 5.66 million baht, 4.44 million baht, and 1.49 million baht, respectively, or 0.81%, 0.61%, and 0.21% of total revenue, respectively. These items arose due to fluctuations in foreign exchange rates as the company must pay for medical device products in foreign currencies. If economic conditions cause the Thai Baht to tend to weaken or strengthen against foreign currencies, especially the US Dollar and Euro, which are the main foreign currencies the company uses to pay its manufacturers, it will affect the company's performance in terms of exchange rate gains (losses). The company mitigates this exchange rate risk by entering into forward foreign exchange contracts with financial institutions. The company does not have a policy of speculating on exchange rate fluctuations.
As of December 31, 2023, December 31, 2024, and December 31, 2025, the company had forward foreign exchange contracts with financial institutions as shown in the table below:
Forward foreign exchange contracts | Foreign currency amount (Unit: Million foreign currency) | Amount in Baht (Unit: Million Baht) | ||||
December 31, 2023 | December 31, 2024 | December 31, 2025 | December 31, 2023 | December 31, 2024 | December 31, 2025 | |
US Dollar | - | 0.04 | - | - | 1.40 | - |
Furthermore, the fair value of outstanding forward foreign exchange contracts as of December 31, 2023, December 31, 2024, and December 31, 2025, is as follows:
Forward foreign exchange contracts | Amount in Baht (Unit: Million Baht) | ||
December 31, 2023 | December 31, 2024 | December 31, 2025 | |
US Dollar | - | 1.40 | - |
As of December 31, 2023, December 31, 2024, and December 31, 2025, the company had significant foreign currency assets and liabilities that were not hedged against exchange rate risk, as follows:
Foreign currency | Foreign currency assets Unit: Million foreign currency | Foreign currency liabilities Unit: Million foreign currency | ||||
December 31, 2023 | December 31, 2024 | December 31, 2025 | December 31, 2023 | December 31, 2024 | December 31, 2025 | |
US Dollar | - | - | - | 3.47 | 3.09 | 0.79 |
Euro | - | - | - | 0.26 | 0.14 | 0.04 |
Yen | - | - | - | 2.21 | 3.78 | - |
Australian Dollar | - | - | - | 0.10 | 0.11 | 0.03 |
Yuan | - | - | - | 0.28 | 7.33 | 0.37 |
Swedish Krona | - | - | - | 2.24 | 1.68 | 1.02 |
Financial costs
For the years 2023 – 2025, the company's financial costs amounted to 15.58 million baht, 19.97 million baht, and 13.32 million baht, respectively, or a financial cost to total revenue ratio of 2.22%, 2.73%, and 1.88%, respectively. The company's significant financial costs include interest on loans from financial institutions such as promissory notes (P/N), import financing (Trust Receipt: T/R), and long-term loan interest.
In 2023, the company's financial costs amounted to 15.58 million baht, representing a financial cost to total revenue ratio of 2.22%. This was an increase of 9.31 million baht or 148.48% compared to the previous year, due to the company increasing its trust receipt loans for importing goods to be used as working capital by 3.70 million baht. Additionally, financial institutions raised interest rates, and TM Nursing Care Co., Ltd. drew down loans for the construction of Building B of The Parents project, resulting in higher financial costs of 5.60 million baht.
For the year 2024, the company's financial costs amounted to 19.97 million baht, representing a financial cost to total revenue ratio of 2.73%. This was an increase of 4.39 million baht or 28.18% compared to the previous year, due to the company increasing its trust receipt loans for importing goods to be used as working capital. Additionally, financial institutions raised interest rates, and The Parents Co., Ltd. drew down loans for the construction of Building B of The Parents project, resulting in higher interest burdens.
And in 2025, the company's financial costs amounted to 13.32 million baht, representing a financial cost to total revenue ratio of 1.88%. This was a decrease of 6.65 million baht or -33.30% compared to the previous year, due to a reduction in the company's trust receipt loans for importing goods, as they were used as internal working capital, and The Parents Co., Ltd. made loan repayments for the construction of Building B of The Parents project, resulting in a reduced interest burden.
Gross profit margin and net profit (loss)
For the years 2023 – 2025, the company's gross profit amounted to 237.17 million baht, 235.77 million baht, and 252.70 million baht, respectively, or a gross profit margin to total revenue of 33.75%, 32.29%, and 35.71%, respectively.
In 2023, the company's gross profit from sales for 2023 was 237.17 million baht, an increase of 14.50 million baht or 6.34% compared to the same period of the previous year, which is consistent with the increased sales volume, stemming from increased sales of new products such as Alcohol ball and blood bank products. The company incurred a gross loss from services for 2023 of 12.53 million baht, as it was the initial period of the subsidiary's operations.
In 2024, the company's gross profit from sales for 2024 was 235.77 million baht, a decrease of 1.40 million baht or 0.59% compared to the same period of the previous year. This is consistent with the increased sales volume, but the company had to reduce selling prices to compete with current price competition. Nevertheless, the company continued to increase sales of new products such as Alcohol Pad, TM Extension with T-connector, and blood bank products. The company incurred a gross loss from services for 2024 of 8.63 million baht, a decrease of 3.90 million baht or 31.12% compared to the same period of the previous year, due to an increase in service users and the opening of an additional Traditional Chinese Medicine acupuncture department.
And in 2025, the company's gross profit from sales for 2024 was 252.70 million baht, an increase of 16.93 million baht or 7.18% compared to the same period of the previous year, which is consistent with sales volume. This was due to the company's policy of offering new products with a gross profit margin of 15% or more, leading to an increase in gross profit compared to 2024. However, the company also had to reduce selling prices to compete with current price competition, and the distributorship for blood bank products was terminated, resulting in decreased sales. The subsidiary incurred a gross loss from services for 2024 of 5.26 million baht, a decrease of 3.37 million baht or 39.04% compared to the same period of the previous year, due to an average of 40 service users per month.
Considering the net profit (loss), it was found that for the years 2023 – 2025, the company had a net loss of -11.92 million baht, -31.14 million baht, and a net profit of 22.07 million baht, respectively, or a net profit margin of -1.70%, -4.26%, and 3.12%, respectively.
For the year 2023, the company reported a net loss of -11.92 million baht, or a net profit (loss) margin to total revenue of -1.71%. This was a decrease of 23.00 million baht or -207.58% compared to the same period of the previous year, primarily due to The Parents Co., Ltd. having a net loss of 35.13 million baht, which resulted in a consolidated net loss compared to 2022. However, if considering the separate financial statements, TM had a net profit of 23.97 million baht, and TM Trading Co., Ltd. had a net profit of 1.88 million baht.
In 2024, the company reported a net loss of -31.14 million baht, or a net loss margin to total revenue of -4.26%. The loss increased by 19.22 million baht or 161.24% from 2023 compared to the same period of the previous year. This was due to the subsidiary group incurring a net loss of 47.48 million baht, which resulted in a consolidated net loss compared to 2023. However, if considering the separate financial statements, TM had a net profit of 14.71 million baht, and TM Trading Co., Ltd. had a net profit of 2.80 million baht.
In 2025, the company's net profit was 22.07 million baht, or a net profit margin to total revenue of 3.12%. The profit increased by 53.21 million baht or 170.87% from 2024 compared to the same period of the previous year, which had a net loss. This was due to the company's policy of offering new products with a gross profit margin of 15% or more, leading to an increase in net profit. The subsidiary group incurred a net loss of 27.22 million baht, which resulted in an increase in consolidated net profit compared to 2024. However, if considering the separate financial statements, TM had a net profit of 45.06 million baht, and TM Trading Co., Ltd. had a net profit of 4.65 million baht.
Return on Equity
The company's return on equity for 2023, 2024, and 2025 was 2.51%, -7.06%, and 5.08%, respectively. The return on equity ratio in 2025 increased from 2024 due to the company's increased net profit. However, the subsidiary incurred a net loss of 27.22 million baht.
Liquidity & Capital Adequacy
Financial Structure Ratios
The Company's debt-to-equity ratio as of December 31, 2023, 2024, and 2025 was 1.13 times, 1.16 times, and 0.94 times, respectively. The Company's debt-to-equity ratio decreased due to the repayment of institutional loans for matured inventory purchases and the repayment of long-term loans for the construction costs of The Parents project (subsidiary).
Liquidity
As of December 31, 2023, the Company's current ratio was 1.39 times. Current assets increased, which is related to increased sales. Concurrently, The Parents Co., Ltd. (formerly TM Nursing Care Co., Ltd.) experienced an increase in current liabilities due to drawing down long-term loans for the construction costs of The Parents project, thus leading to a decrease in the current ratio compared to 2022.
As of December 31, 2024, the Company's current ratio was 1.35 times. Current assets decreased slightly compared to 2023, which is related to The Parents Co., Ltd. having reduced current liabilities due to the repayment of long-term loans for the construction costs of The Parents project, thus leading to a decrease in the current ratio compared to 2023.
As of December 31, 2025, the Company's current ratio was 1.50 times. Current assets increased compared to 2024, which is related to the Company's sales. Additionally, The Parents Co., Ltd. experienced a decrease in current liabilities due to the repayment of long-term loans for the construction costs of The Parents project.
Furthermore, considering the quick ratio, as of December 31, 2023, 2024, and 2025, the Company's quick ratio was 0.75 times, 0.73 times, and 0.89 times, respectively. In 2024 and 2025, the Company's quick ratio increased.
And considering the Cash Conversion Cycle, as of December 31, 2023, 2024, and 2025, the Company's cash conversion cycle was 205 days, 203 days, and 201 days, respectively. The Company's cash conversion cycle is relatively long and decreased slightly in 2025 because the Company has a long collection period for government hospital customers, which is typical for sales to such government hospitals.
Furthermore, from 2023 to 2025, the Company sold goods on trade credit to hospitals, with an average collection period of 90-120 days for government hospitals, 30-60 days for private hospitals, and cash or 7-90 days for clinics and medical personnel. The decrease in the cash conversion cycle ratio as of December 31, 2023-2025, resulted from a slight reduction in the average collection period, as the turnover rate of trade receivables slowed down due to some government hospital debtors whose payments could be tracked more effectively, but still required waiting for disbursements according to the government's budget cycle, typically in the fourth quarter of each year. The average sales period increased due to a constant inventory turnover ratio, stemming from a slight decrease in the Company's inventory, particularly in the category of equipment and consumables for central sterile supply departments and operating rooms, which have a relatively fast sales rate. Concurrently, the payment period for trade payables slightly lengthened. Meanwhile, the proportion of the Company's trade payables decreased, specifically from suppliers of equipment and consumables for central sterile supply departments of hospitals, where sales declined due to manufacturers increasing product costs and intensified market competition. This necessitated a slowdown in ordering goods, and in some cases, payment for goods was required before receipt.
Considering the interest coverage ratio, as of December 31, 2023, 2024, and 2025, the Company's interest coverage ratio was -0.78 times, 24.01 times, and 33.68 times, respectively. This indicates an increase in the Company's ability to pay interest, despite a decrease in the Company's operating cash flow. Particularly in 2025, the subsidiary's continuous losses resulted in a slight increase in the interest coverage ratio.
Considering the debt service coverage ratio, as of December 31, 2023, 2024, and 2025, the Company's debt service coverage ratio was -0.24 times, 14.18 times, and 23.99 times, respectively.
In 2023, the Company's ability to meet its obligations was positive despite negative cash flow from operating activities due to the subsidiary's losses. However, when considering the Company's separate financial statements, cash flow from operating activities in 2023 was positive due to collections from debtors.
And in 2024, the Company's ability to meet its obligations was positive due to positive cash flow from operating activities in 2024, resulting from collections from trade receivables.
And in 2025, the Company's ability to meet its obligations was positive due to positive cash flow from operating activities in 2025, resulting from collections from trade receivables.
Cash flow for the years ended December 31, 2023, 2024, and 2025
Net cash provided by (used in) operating activities
In 2023, the Company used cash from operating activities amounting to 17.82 million Baht, resulting from a pre-tax loss of 11.92 million Baht and an increase in sales leading to higher inventory.
For the year 2024, the Company had cash receipts from operating activities totaling 464.80 million Baht. This was due to the Company's efforts to manage inventory to meet demand, resulting in faster inventory turnover, coupled with increased sales and quicker collection of receivables.
For the year 2025, the Company had cash receipts from operating activities totaling 443.88 million Baht. This was due to the Company's efforts to manage inventory to meet demand, resulting in faster inventory turnover, coupled with increased sales and quicker collection of receivables.
Net cash provided by (used in) investing activities
In 2023, the Company had cash outflows from investing activities totaling 52.83 million Baht, primarily due to cash outflows for investments in buildings and equipment amounting to 54.15 million Baht for the construction of The Parents project, and an increase in intangible assets of 0.02 million Baht.
For the year 2024, the Company had cash receipts from investing activities totaling 18.46 million Baht, primarily due to the recovery of net assets from a subsidiary's liquidation amounting to 28.91 million Baht, while the subsidiary also increased its fixed asset purchases during the period by 8.34 million Baht.
For the year 2025, the Company had cash outflows from investing activities totaling 4.02 million Baht, primarily due to cash outflows for investments in buildings and equipment amounting to 5.64 million Baht. Concurrently, there was cash received from earthquake insurance claims totaling 0.26 million Baht.
Net cash provided by (used in) financing activities
For the year 2023, the Company had cash from financing activities totaling 42.97 million Baht. This was due to an increase in long-term loans of 19.97 million Baht and an increase in short-term loans from financial institutions of 66.46 million Baht, as well as dividend payments during the period of 15.40 million Baht, interest payments of 15.83 million Baht, and lease liability payments of 6.49 million Baht.
For the year 2024, the Company utilized cash from financing activities totaling 511.43 million Baht. This was primarily due to the repayment of short-term loans from financial institutions amounting to 464.27 million Baht, dividend payments during the period of 10.16 million Baht, interest payments of 19.46 million Baht, lease liability payments of 5.71 million Baht, and repayment of short-term loans from related parties totaling 29.00 million Baht.
For the year 2025, the Company utilized cash from financing activities totaling 441.82 million Baht. This was due to the repayment of short-term loans from financial institutions amounting to 409.27 million Baht, repayment of long-term loans of 12.86 million Baht, interest payments of 14.03 million Baht, and lease liability payments of 5.66 million Baht.
Capital Expenditures
The Company's capital expenditures in 2023, 2024, and 2025 were aimed at investing in office building improvements, including office equipment and vehicles, to support future business growth. Details of the capital expenditures are as follows:
Table of Capital Expenditure Details
Unit: Million Baht
2023 | 2024 | 2025 | |
Capital expenditures in fixed assets | 54.15 /1 | 10.78 /1 | 5.65 /1 |
Capital expenditures in subsidiaries (in separate financial statements) | - | - | - |
Note : /1 The Company established a subsidiary named The Parents Co., Ltd. on January 16, 2020, with a registered capital of 125,000,000 Baht. The Company holds an 80% stake in the subsidiary. The subsidiary was established to build a hospital and elderly care facility to support the future growth of the healthcare business.
For the year 2024, The Parents Co., Ltd. purchased medical equipment and supplies, which were capitalized as assets. Depreciation began to be recorded in January.
For the year 2025, the Company purchased office equipment, computers, and connectivity devices, which were capitalized as assets. Depreciation began to be recorded in January.
Asset Management Capability
Assets
As of December 31, 2023, 2024, and 2025, the Company's total assets amounted to Baht 983.34 million, Baht 908.17 million, and Baht 869.92 million, respectively. Significant asset items affecting the change in the Company's total assets are as follows:
Current Assets
As of December 31, 2023, 2024, and 2025, the Company's current assets amounted to Baht 545.91 million, Baht 497.39 million, and Baht 476.66 million, respectively, representing a proportion of total assets of 55.52%, 54.77%, and 54.79%, respectively. Details of each significant item are as follows:
Cash and Cash Equivalents
As of December 31, 2023, 2024, and 2025, the values were Baht 72.39 million, Baht 44.22 million, and Baht 42.26 million, respectively, representing a proportion of total assets of 7.36%, 4.87%, and 4.86%, respectively. As of December 31, 2025, cash and cash equivalents decreased by Baht 1.96 million, or 4.43%, from December 31, 2024. The main reasons for the decrease in cash and cash equivalents were net long-term loan repayments during the period totaling Baht 12.86 million, and interest payments of Baht 14.03 million.
Trade Accounts Receivable
As of December 31, 2023, 2024, and 2025, the values were Baht 220.93 million, Baht 224.81 million, and Baht 241.47 million, respectively, representing a proportion of total assets of 22.47%, 24.75%, and 27.76%, respectively.
Comparing trade accounts receivable as of December 31, 2022, and 2023, it can be observed that the Company's trade accounts receivable increased by Baht 17.46 million, or 8.58% from 2022. This increase was due to a rise in sales of surgical equipment and consumables by Baht 49.56 million, and laboratory and blood bank equipment and consumables by Baht 20.82 million. Nevertheless, the Company was able to collect more outstanding debts. The Company recognized an impairment loss on financial assets (allowance for doubtful accounts) of Baht 0.29 million.
Comparing trade accounts receivable as of December 31, 2023, and 2024, it can be observed that the Company's trade accounts receivable increased by Baht 3.88 million, or 1.76% from 2023. This increase was due to a rise in sales of surgical equipment and consumables by Baht 28.78 million, and laboratory and blood bank equipment and consumables by Baht 1.50 million. Nevertheless, the Company was able to collect more outstanding debts. The Company recognized an impairment loss on financial assets (allowance for doubtful accounts) of Baht 0.37 million.
Comparing trade accounts receivable as of December 31, 2024, and 2025, it can be observed that the Company's trade accounts receivable increased by Baht 16.66 million, or 7.41% from 2024. This increase was due to a rise in sales of surgical equipment and consumables by Baht 1.44 million. However, government hospitals faced budget shortages and required government funding to make payments. Nevertheless, the Company was able to collect more outstanding debts. The Company recognized an impairment loss on financial assets (allowance for doubtful accounts) of Baht 0.01 million.
The Company's trade accounts receivable consist of trade receivables and post-dated checks. The Company has a credit term policy for various customer types as follows:
Customer Type | Credit Term Policy |
Government Hospitals | 90 - 120 days |
Private Hospitals | 60 – 90 days |
Clinics and Medical Personnel | Cash or 7-90 days |
Regarding the Company's policy for determining the allowance for expected credit losses (doubtful accounts), the Company primarily sets aside a full allowance for debts outstanding for more than 12 months and calculates it in accordance with Financial Reporting Standard No. 9 (TFRS 9), which is a standard related to financial instruments with the main objective of preparing financial reports for financial assets and financial liabilities and reflecting credit losses.
However, based on payment collection history from 2023 – 2025, the Company has not incurred any significant bad debts from customer collections. This is because most of the Company's debtors are government and private hospitals or medical facilities with efficient payment capabilities. Therefore, the Company has never encountered issues with uncollectible debts. Furthermore, the Company has a policy to follow up on debts from customers through its sales representatives, who are fully responsible for tracking payments from customers assigned to their respective teams.
For the years 2023 – 2025, the Company's average collection period was 110 days, 112 days, and 120 days, respectively.
(Unit: Million Baht)
Trade Accounts Receivable Value | Dec 31, 2023 | % | Dec 31, 2024 | % | Dec 31, 2025 | % |
Not yet due | 145.11 | 65.60 | 151.17 | 67.05 | 151.49 | 62.56 |
Overdue | ||||||
| 52.48 | 23.72 | 55.62 | 24.67 | 61.66 | 25.47 |
| 15.03 | 6.79 | 12.77 | 5.66 | 17.86 | 7.37 |
| 7.68 | 3.47 | 5.43 | 2.40 | 10.80 | 4.46 |
| 0.92 | 0.42 | 0.49 | 0.22 | 0.33 | 0.14 |
Total | 221.22 | 100.00 | 225.48 | 100.00 | 242.14 | 100.00 |
Less: Allowance for doubtful accounts | (0.29) | 0.13 | (0.66) | 0.29 | (0.67) | 0.28 |
Total Trade Accounts Receivable | 220.93 | 99.87 | 224.81 | 99.71 | 241.47 | 99.72 |
As of December 31, 2023, the majority of trade accounts receivable remained not yet due, amounting to Baht 145.11 million, or 65.60% of total receivables, with overdue receivables totaling Baht 76.11 million, or 34.40%. However, trade accounts receivable overdue for more than 12 months amounted to Baht 0.92 million, or 0.42%, which are receivables from government hospitals or medical facilities that have the ability and efficiency to pay but could not pay on time due to awaiting government budget support. The Company expects to collect the full amount and there is no risk of uncollectible debts. An allowance for doubtful accounts totaling Baht 0.29 million was recorded in 2023.
As of December 31, 2024, the majority of trade accounts receivable remained not yet due, amounting to Baht 151.17 million, or 67.05% of total receivables, with overdue receivables totaling Baht 74.30 million, or 32.95%. However, trade accounts receivable overdue for more than 12 months amounted to Baht 0.49 million, or 0.49%, which are receivables from government hospitals or medical facilities that have the ability and efficiency to pay but could not pay on time due to awaiting government budget support. The Company expects to collect the full amount and there is no risk of uncollectible debts. An allowance for doubtful accounts totaling Baht 0.66 million was recorded in 2024.
As of December 31, 2025, the majority of trade accounts receivable remained not yet due, amounting to Baht 151.49 million, or 62.56% of total receivables, with overdue receivables totaling Baht 90.65 million, or 37.44%. However, trade accounts receivable overdue for more than 12 months amounted to Baht 0.33 million, or 0.14%, which are receivables from government hospitals or medical facilities that have the ability and efficiency to pay but could not pay on time due to awaiting government budget support. The Company expects to collect the full amount and there is no risk of uncollectible debts. An allowance for doubtful accounts totaling Baht 0.01 million was recorded in 2025.
Inventories
As of December 31, 2023, 2024, and 2025, the values were Baht 221.72 million, Baht 186.34 million, and Baht 148.17 million, respectively, representing a proportion of total assets of 22.55%, 20.52%, and 17.03%, respectively. Details are provided in the following table:
(Unit: Million Baht)
Inventory Value | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
Goods Held for Sale | 208.94 | 167.23 | 132.95 |
Goods in Transit | 23.34 | 31.74 | 24.53 |
Total | 232.27 | 198.97 | 157.48 |
Less: Allowance for obsolete/deteriorated inventory | (10.55) | (12.63) | (9.31) |
Inventories - Net | 221.72 | 186.34 | 148.17 |
Comparing inventories as of December 31, 2024, and 2025, it was found that the Company's inventory decreased by Baht 38.17 million, or 20.48%. This aligns with the decrease in sales and is due to the fact that in 2025, demand for surgical equipment and consumables increased as hospitals resumed normal surgical operations. The Company has also endeavored to reduce inventory levels to increase inventory turnover and must place orders to maintain stock according to customer demand.
The main components of inventory are goods held for sale and goods in transit. As the Company is engaged in the business of selling medical instruments and equipment, it must order goods to meet customer demand and consider the lead time for delivery. The Company manages its purchase orders and delivers goods to customers on schedule, owing to its long business experience and efficient purchasing planning. Goods in transit are goods currently being transported and involve various shipping terms such as EXW (Ex Works), FOB (Free On Board), FCA (Free Carrier), CIF (Cost, Insurance & Freight), and CIP (Carriage and Insurance Paid).
Considering the average inventory turnover period during 2023 - 2025, the Company had an average inventory turnover period of 154 days, 149 days, and 132 days, respectively. As the Company imports all medical instruments and equipment from abroad, it must plan its orders and maintain a diverse inventory to meet customer demand.
The Company establishes an allowance for obsolete/deteriorated inventory based on the age of the goods. The Company's policy for setting an allowance for obsolete inventory considers goods that have not turned over for more than one year or goods nearing expiration (within 6 months before expiration). If such goods are found to be nearing expiration, obsolete, or have decreased in value, the Company recognizes a loss from obsolete inventory as an expense in the income statement and establishes an allowance for obsolete inventory to reduce the value of inventory. The Company began setting aside provisions for deteriorated and expired inventory as of December 31, 2023, with an allowance for deteriorated and expired inventory of Baht 10.55 million. As of December 31, 2024, the allowance for deteriorated and expired inventory was Baht 12.63 million, and as of December 31, 2025, it was Baht 9.31 million.
Other Receivables
As of December 31, 2023, 2024, and 2025, the Company's other receivables amounted to Baht 30.87 million, Baht 42.02 million, and Baht 39.66 million, respectively, representing a proportion of total assets of 3.14%, 4.63%, and 4.56%, respectively. These primarily consist of VAT and input tax not yet due, and advance payments for goods.
As of December 31, 2023, the Company's other receivables decreased by Baht 2.38 million, or 7.16% compared to December 31, 2022. The increase in other receivables consisted of VAT and input tax not yet due, a decrease in employee advances, a decrease in advance payments for goods, and simultaneously, other receivables from The Parents Co., Ltd. increased by Baht 2.33 million, comprising VAT receivables from building construction not yet claimed for refund.
Meanwhile, as of December 31, 2024, the Company's other receivables increased by Baht 11.15 million, or 36.12% compared to December 31, 2023. The increase in other receivables consisted of VAT and input tax not yet due, employee advances, and advance payments for goods.
Meanwhile, as of December 31, 2025, the Company's other receivables decreased by Baht 2.36 million, or 5.62% compared to December 31, 2024. The decrease in other receivables consisted of VAT and input tax not yet due, employee advances, and advance payments for goods.
Short-term Loans to Other Entities
As of December 31, 2025, the Company had short-term loans to other entities totaling Baht 5.10 million. These loans were advances for the procurement of 5 specialized medical equipment items for the Company to sell to customers in the normal course of business, with the goods serving as collateral for the contract.
Bank Deposits Pledged as Collateral
As of December 31, 2023, 2024, and 2025, the Company had bank deposits pledged as collateral totaling Baht 8.00 million, Baht 8.00 million, and Baht 8.00 million, respectively, representing a proportion of total assets of 0.81%, 0.88%, and 0.92%, respectively. These deposits are pledged with a bank to secure the Company's credit facilities.
Land, Buildings, and Equipment - Net
As of December 31, 2023, 2024, and 2025, the Company's net land, buildings, and equipment amounted to Baht 405.45 million, Baht 378.69 million, and Baht 361.28 million, respectively, representing a proportion of total assets of 41.23%, 41.70%, and 41.53%, respectively.
Comparing land, buildings, and equipment in 2023 and 2024, it was found that the value of land, buildings, and equipment decreased by Baht 26.76 million, or 6.60%. This was due to an increase in medical equipment/instruments for demonstration by Baht 7.24 million, an increase in office equipment/furniture by Baht 1.17 million, an increase in computer equipment by Baht 0.16 million, and recorded depreciation of Baht 17.32 million.
And in 2024, the net buildings and building improvements and equipment of The Parents Co., Ltd. increased by Baht 6.64 million, consisting of building construction, land improvements, and fixed assets for The Parents Wellness and Rehabilitation Center project. The subsidiary recorded accumulated depreciation of Baht 11.58 million. In Q3/2024, The Parents Hospital Co., Ltd. received approval for dissolution and therefore recognized an impairment loss or write-off totaling Baht 14.94 million.
Comparing land, buildings, and equipment in 2024 and 2025, it was found that the value of land, buildings, and equipment decreased by Baht 17.41 million, or 4.60%. This was due to the Company recording depreciation of Baht 17.10 million, an increase in medical equipment/instruments for demonstration by Baht 5.58 million, an increase in office equipment/furniture by Baht 1.21 million, an increase in computer equipment by Baht 1.10 million, and the subsidiary recording accumulated depreciation of Baht 14.60 million.
Liabilities
As of December 31, 2023, 2024, and 2025, the Company's total liabilities amounted to Baht 521.90 million, Baht 488.04 million, and Baht 421.42 million, respectively, representing a proportion of total liabilities and shareholders' equity of 53.07%, 53.74%, and 66.62%, respectively. The total liabilities to shareholders' equity ratio during the past period was 1.13 times, 1.16 times, and 0.94 times, respectively. Significant changes in liabilities are as follows:
Current Liabilities
As of December 31, 2023, 2024, and 2025, the Company's total current liabilities amounted to Baht 392.94 million, Baht 367.13 million, and Baht 317.62 million, respectively, representing a proportion of total liabilities and shareholders' equity of 39.96%, 40.43%, and 36.51%, respectively. Details of each significant item are as follows:
Bank Overdrafts and Short-term Loans from Financial Institutions
As of December 31, 2023, 2024, and 2025, the values were Baht 257.98 million, Baht 234.05 million, and Baht 218.09 million, respectively, representing a proportion of total liabilities and shareholders' equity of 26.24%, 25.77%, and 25.07%, respectively. Short-term loans from financial institutions consist of promissory notes and trust receipt loans. Promissory note loans with a maturity of not exceeding 365 days have an annual interest rate equal to MMR, while trust receipt loans (maturing within 36 months) have an annual interest rate equal to MMR. These credit facilities are used for paying for goods and as working capital for business operations.
As of December 31, 2023, the Company had promissory note loans totaling Baht 70.00 million, due to payments made during the year when the promissory notes matured, and trust receipt loans totaling Baht 187.98 million, an increase of Baht 14.29 million from 2022. The trust receipt loan facility is a revolving credit line used for the Company's normal business operations.
As of December 31, 2024, the Company had promissory note loans totaling Baht 105.00 million, due to payments made during the year when the promissory notes matured, and trust receipt loans totaling Baht 129.05 million, a decrease of Baht 58.93 million from 2023. The trust receipt loan facility is a revolving credit line used for the Company's normal business operations.
As of December 31, 2025, the Company had promissory note loans totaling Baht 95 million, due to payments made during the year when the promissory notes matured, and trust receipt loans totaling Baht 123.09 million, a decrease of Baht 15.96 million from 2024. The trust receipt loan facility is a revolving credit line used for the Company's normal business operations.
Trade Accounts Payable
As of December 31, 2023, 2024, and 2025, the values were Baht 80.75 million, Baht 83.74 million, and Baht 48.17 million, respectively, representing a proportion of total liabilities and shareholders' equity of 8.21%, 9.22%, and 5.54%, respectively.
In 2025, the Company's trade accounts payable decreased by Baht 35.57 million, or 42.48% compared to December 31, 2024, due to a reduction in the Company's purchase orders, which is related to the decrease in sales volume. However, the Company continues to maintain sufficient inventory to meet demand. The Company receives credit terms from trade creditors of approximately 60-90 days, depending on the payment terms of each trade creditor. In 2025, the maturity of debts led to a decrease in trade accounts payable. The payment periods for debts in 2023 and 2025 were 60 days, 61 days, and 52 days, respectively.
Other Payables
As of December 31, 2023, 2024, and 2025, the Company's other payables amounted to Baht 36.15 million, Baht 29.92 million, and Baht 27.60 million, respectively, representing a proportion of total liabilities and shareholders' equity of 3.68%, 3.29%, and 3.17%, respectively. These consist of accrued employee bonuses, accrued commissions, accrued withholding tax, accrued social security contributions, and accrued provident fund contributions, among others.
For the year 2023, the Company's other payables decreased by Baht 7.82 million, or 17.78% from the balance as of December 31, 2022, as the Company transferred advance payments for goods brought forward from the beginning of the year to sales revenue, resulting in a decrease in advance payments for goods by Baht 2.13 million in 2023, and a decrease in accrued expenses and discounts on receivables by Baht 0.44 million. The Parents Co., Ltd. also made payments to other payables. For the year 2024, the Company's other payables decreased by Baht 6.23 million, or 17.23% from the balance as of December 31, 2023, due to the payment of the 2023 annual bonus totaling Baht 8.00 million.
And in 2025, the Company's other payables decreased by Baht 2.32 million, or 7.75% from the balance as of December 31, 2024, due to the payment of matured debts for internal company consumables.
Non-current Liabilities
As of December 31, 2023, 2024, and 2025, the Company's total non-current liabilities amounted to Baht 128.96 million, Baht 120.91 million, and Baht 103.80 million, respectively, representing a proportion of total liabilities and shareholders' equity of 13.11%, 13.31%, and 11.93%, respectively. Significant changes in non-current liabilities are as follows:
Long-term Loans
As of December 31, 2023, 2024, and 2025, the Company's long-term loan obligations amounted to Baht 105.60 million, Baht 94.26 million, and Baht 80.24 million, respectively, representing a proportion of total liabilities and shareholders' equity of 10.74%, 10.38%, and 9.22%, respectively.
In 2023, The Parents Co., Ltd. drew down long-term loans for building construction totaling Baht 105.60 million (from a credit line of Baht 230 million). In 2024, The Parents Co., Ltd. repaid long-term loans totaling Baht 11.82 million.
And in 2025, The Parents Co., Ltd. repaid long-term loans totaling Baht 12.86 million.
Post-employment Benefit Obligations
As of December 31, 2023, 2024, and 2025, the Company's post-employment benefit obligations amounted to Baht 17.28 million, Baht 19.85 million, and Baht 14.38 million, respectively, representing a proportion of total liabilities and shareholders' equity of 1.76%, 2.57%, and 1.65%, respectively. The Company has obligations for payments to employees upon termination of employment in accordance with labour laws. The Company considers such compensation as a post-employment benefit plan for employees, and the liabilities under the employee post-employment benefit plan are calculated using the projected unit credit method, with independent experts assessing these obligations based on actuarial principles and.
As of December 31, 2025, the Company's post-employment benefit obligations amounted to Baht 14.38 million, a decrease of Baht 5.47 million, or 27.56%. This was due to a new calculation of employee retirement provisions every 3 years by actuaries. During the year, a provision for employee retirement benefits of Baht 2.20 million was recorded, and retirement compensation payments of Baht 1.00 million were made. In 2023, the subsidiary considered recording a provision for employee retirement benefits in Q3/2023, and in 2025, a provision for employee retirement benefits of Baht 2.04 million was recorded.
Shareholders' Equity
As of December 31, 2023, 2024, and 2025, the Company's total shareholders' equity amounted to Baht 461.43 million, Baht 420.13 million, and Baht 448.50 million, respectively, representing a proportion of total liabilities and shareholders' equity of 46.93%, 46.26%, and 51.56%, respectively. Significant changes in shareholders' equity are as follows:
Issued and Paid-up Registered Capital
As of December 31, 2023, the Company had registered capital of Baht 205.33 million, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 shares in 2021, with a par value of Baht 0.50 per share. The issued and fully paid-up capital consisted of 307,999,987 ordinary shares, with a par value of Baht 0.50 per share.
As of December 31, 2024, the Company had registered capital of Baht 205.33 million, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 shares in 2021, with a par value of Baht 0.50 per share. The issued and fully paid-up capital consisted of 307,999,987 ordinary shares, with a par value of Baht 0.50 per share.
As of December 31, 2025, the Company had registered capital of Baht 205.33 million, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 shares in 2021, with a par value of Baht 0.50 per share. The issued and fully paid-up capital consisted of 308,000,178 ordinary shares, with a par value of Baht 0.50 per share.
Share Premium
As of December 31, 2023, 2024, and 2025, the Company had share premium of Baht 184.04 million (net of share issuance costs of Baht 15.97 million), representing a proportion of total liabilities and shareholders' equity of 18.71%, 20.26%, and 21.16%, respectively.
Legal Reserve
As of December 31, 2023, 2024, and 2025, the values were Baht 17.64 million, Baht 18.38 million, and Baht 20.53 million, respectively. These are reserves under the Civil and Commercial Code. The Company must allocate a reserve of at least 5% of its annual net profit each time dividends are declared until the reserve equals 10% of the Company's registered capital. This reserve cannot be used for dividend payments. However, in 2025, the Company increased its allocated reserve by Baht 2.15 million, having fully met the legal reserve requirement of 10% of its registered capital in 2025.
Retained Earnings - Unappropriated
As of December 31, 2023, 2024, and 2025, the Company's unappropriated retained earnings amounted to Baht 56.02 million, Baht 23.48 million, and Baht 55.13 million, respectively, representing a proportion of total liabilities and shareholders' equity of 5.70%, 2.59%, and 6.34%, respectively. The increase in retained earnings resulted from the net profit generated from the Company's operations each year, net of dividends paid and legal reserve appropriations. However, The Parents Co., Ltd. continued to incur losses, resulting in a slight increase in unappropriated retained earnings.
In 2023, the Company's unappropriated retained earnings amounted to Baht 56.02 million, a decrease of Baht 21.09 million, or 27.35% compared to unappropriated retained earnings as of December 31, 2022. This was due to dividend payments of Baht 15.40 million and the appropriation of profit to legal reserve totaling Baht 1.20 million. Meanwhile, the Company had a total comprehensive loss attributable to the parent company for 2023 of Baht 4.49 million, resulting in a decrease in the Company's retained earnings compared to 2022. In 2023, The Parents Co., Ltd. reported a net loss of Baht 35.13 million.
In 2024, the Company's unappropriated retained earnings amounted to Baht 23.48 million, a decrease of Baht 32.54 million, or 58.09% compared to unappropriated retained earnings as of December 31, 2023. This was due to dividend payments of Baht 10.16 million and the appropriation of profit to legal reserve totaling Baht 0.74 million. Meanwhile, the Company had a total comprehensive loss attributable to the parent company for 2024 of Baht 21.64 million, resulting in a decrease in the Company's retained earnings compared to 2023. In 2024, The Parents Co., Ltd. reported a net loss of Baht 47.48 million.
In 2025, the Company's unappropriated retained earnings amounted to Baht 55.13 million, an increase of Baht 31.65 million, or 134.80% compared to unappropriated retained earnings as of December 31, 2024. This was due to the Company having a net operating profit of Baht 45.06 million and the appropriation of profit to legal reserve totaling Baht 2.15 million. Meanwhile, the Company had a total comprehensive income attributable to the parent company for 2025 of Baht 22.07 million, resulting in an increase in the Company's retained earnings compared to 2024. In 2025, The Parents Co., Ltd. reported a net loss of Baht 27.22 million.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
Exchange rate fluctuations
Most of the products sold by the company are imported from abroad, and pricing and payment for goods are primarily conducted in US dollars. In contrast, all products sold by the company domestically are in Thai Baht. When the Thai Baht depreciates against the US dollar, the amount the company must pay for goods increases, which may lead to a rise in the company's cost of goods sold. Conversely, if the Thai Baht appreciates, the company's product costs may decrease, and it also impacts exchange rate gains (losses).
However, the company enters into forward foreign exchange contracts (Forward Contracts) every time goods are imported from abroad. This allows the company to determine the cost of goods sold and protect against exchange rate fluctuations that could impact the company's operating performance. The execution of such forward foreign exchange contracts is at the discretion of the company's management and in accordance with the operational authority manual approved by the Board of Directors.
The company places importance on exchange rates, thus close monitoring and assessment of exchange rate risks have been established, including tracking trends and movements of foreign currency exchange rates, as well as analyzing various economic news and the trend of the Thai Baht against major foreign currencies.
Price competition
In the competitive market for medical device distribution, pricing is one of the primary pressures influencing customer purchasing decisions, especially for both public and private hospitals that must manage budgets efficiently. The ability to consistently offer competitive prices is therefore crucial. Distributors face competition from existing market experts, new entrants seeking market share, and the trend of suppliers potentially opting for direct sales to customers. All these factors increase price pressure, leading to a tendency for the industry's average profit margins to decrease without careful cost management and pricing strategies.
Sustainable competitive pricing, therefore, does not solely mean price reduction, but also encompasses cost restructuring, enhancing logistics efficiency, and differentiating after-sales services to clearly demonstrate value to customers in a market where customers consider both price and quality.
Furthermore, the ability to efficiently manage inventory and utilize appropriate trade credit terms with suppliers is also a crucial factor that helps the company maintain suitable selling prices without impacting liquidity.
Consistent competitive data analysis and strategic pricing are crucial for success. The company must integrate market data, competitor overviews, and customer needs in its pricing strategy to meet both customer value expectations and generate sustainable returns.
The company has continuously operated as a distributor of medical devices for over 24 years, partnering with more than 70 manufacturers from various countries worldwide. The long-standing good relationships and business collaborations with these manufacturers enhance the company's ability to effectively negotiate prices and trade terms, which is a crucial factor supporting the company's competitiveness in the market.
Furthermore, the company has a team of highly experienced sales staff with in-depth product knowledge and a thorough understanding of the specific needs of each customer segment. This expertise enables the company to offer suitable products, continuously build trust, and ensure customer satisfaction, which is another crucial factor contributing to the company's business strength and long-term sustainable growth.

